DIAMOND BAR, California, March 22, 2017 /PRNewswire/. Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, ...
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO™ 3 System Version 8, the latest version of the company's ...
Johnson & Johnson MedTech’s Biosense Webster division is rolling out a new version of its heart-mapping system that the company says marks its first to employ artificial intelligence capabilities. The ...
The CARTO® 3 System and THERMOCOOL SMARTTOUCH® SF Catheter allow for a patient-tailored ablation approach, resulting in high long-term effectiveness in persistent atrial fibrillation patients* IRVINE, ...
DIAMOND BAR, Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today the launch of the CONFIDENSE™ Module, an innovative technology that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
IRVINE, Calif.--(BUSINESS WIRE)--Apr. 21, 2026-- Johnson & Johnson today announced it will showcase the latest advances across its electrophysiology portfolio at the 2026 Heart Rhythm Society (HRS) ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Johnson & Johnson’s dual energy AF ablation platform. The platform provides both radiofrequency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results